Scarica l'app Stockscreener
52.00
5.07%
2.51
Dopo l'orario di chiusura:
52.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$49.49
Aprire:
$49.8
Volume 24 ore:
1.45M
Relative Volume:
0.73
Capitalizzazione di mercato:
$2.79B
Reddito:
-
Utile/perdita netta:
$-38.99M
Rapporto P/E:
-17.35
EPS:
-2.9966
Flusso di cassa netto:
$-24.94M
1 W Prestazione:
+1.23%
1M Prestazione:
+8.95%
6M Prestazione:
-35.16%
1 anno Prestazione:
+12.36%
Intervallo 1D:
$49.10
$52.79
Intervallo di 1 settimana:
$48.60
$55.47
Portata 52W:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Nome
Soleno Therapeutics Inc
Settore
Industria
Telefono
650-213-8444
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Confronta SLNO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
52.00 | 2.66B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-10-07 | Iniziato | Goldman | Buy |
| 2025-08-20 | Iniziato | Wells Fargo | Overweight |
| 2025-06-23 | Iniziato | TD Cowen | Buy |
| 2025-03-05 | Ripresa | Stifel | Buy |
| 2024-12-02 | Reiterato | Robert W. Baird | Outperform |
| 2024-12-02 | Reiterato | Stifel | Buy |
| 2024-09-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-10 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-05 | Iniziato | Piper Sandler | Overweight |
| 2024-01-23 | Iniziato | Stifel | Buy |
| 2023-11-21 | Ripresa | Guggenheim | Buy |
| 2020-09-29 | Iniziato | Guggenheim | Buy |
| 2020-01-10 | Iniziato | Craig Hallum | Buy |
| 2019-12-23 | Iniziato | Oppenheimer | Outperform |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
Mostra tutto
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno Therapeutics Gains Momentum Following Wolfe Research Favorable Rating - timothysykes.com
Soleno Therapeutics, Inc. $SLNO Shares Sold by Holocene Advisors LP - MarketBeat
Soleno Therapeutics Stock Poised for Growth as Wolfe Research Issues Positive Rating - StocksToTrade
Soleno Therapeutics Rises as Wolfe Research Gives Positive Outlook - timothysykes.com
Adage Capital Partners GP L.L.C. Decreases Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Valuation Update: Will Soleno Therapeutics Inc. stock recover faster than peersJuly 2025 Pullbacks & AI Powered Market Entry Ideas - moha.gov.vn
Soleno Therapeutics (SLNO) Reports Strong Q3 Earnings Despite VYKAT XR Safety Concerns - MSN
Technical Reactions to SLNO Trends in Macro Strategies - news.stocktradersdaily.com
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap UpStill a Buy? - MarketBeat
Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise - Benzinga
Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Insider Monkey
Gainers Report: What insider trading reveals about Soleno Therapeutics Inc stockOil Prices & High Return Trade Guides - moha.gov.vn
Diadema Partners LP Has $23.81 Million Stock Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Stake Reduced by Vivo Capital LLC - MarketBeat
Marshall Wace LLP Purchases 164,580 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Aug Movers: How buybacks impact Soleno Therapeutics Inc stock valueJuly 2025 Big Picture & Real-Time Buy Signal Notifications - moha.gov.vn
Soleno Therapeutics (NASDAQ:SLNO) Nasdaq Index Clinical Pipeline Growth - Kalkine Media
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Russell Investments Group Ltd. Acquires 82,932 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Rhumbline Advisers Acquires 22,607 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - The Malaysian Reserve
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus
Soleno Therapeutics board member William Harris passes away By Investing.com - Investing.com Canada
Will Soleno Therapeutics Inc. stock deliver shareholder valueJuly 2025 Short Interest & Verified High Yield Trade Plans - Newser
Why Soleno Therapeutics Inc. (6XC) stock remains stableEarnings Summary Report & High Accuracy Buy Signal Tips - Newser
Is Soleno Therapeutics Inc. stock in correction or buying zoneEarnings Growth Summary & Technical Pattern Based Buy Signals - Newser
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet? - Nasdaq
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact ... - Enidnews.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Soleno Therapeutics board member William Harris passes away - Investing.com
Soleno Therapeutics Announces the Passing of Board Member William G. Harris - The Manila Times
Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickMarket Weekly Review & Step-by-Step Trade Execution Guides - Newser
How buybacks impact Soleno Therapeutics Inc. stock valueJuly 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
How Does Wolfe Research’s Support Shape Soleno Therapeutics’ (SLNO) Credibility Amid Heightened Scrutiny? - simplywall.st
Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire
Soleno Therapeutics, Inc. (SLNO) Investigation: Bronstein, Gewirt - The National Law Review
Soleno Therapeutics (SLNO): Does Current Valuation Signal Opportunity or Caution for Investors? - Yahoo Finance
Trading the Move, Not the Narrative: (SLNO) Edition - news.stocktradersdaily.com
Could Soleno Therapeutics Have Room to Run After FDA Designation Sparks 11.8% Rally? - Yahoo Finance
ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Soleno - The National Law Review
Handelsbanken Fonder AB Acquires Shares of 10,400 Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics, Inc. $SLNO Shares Sold by F m Investments LLC - MarketBeat
Franklin Resources Inc. Buys New Shares in Soleno Therapeutics, Inc. $SLNO - MarketBeat
12 Best Upside Stocks to Buy Now - Insider Monkey
Analyst Dismisses ViCAT XR Safety Fears, Expects Strong Growth Despite Recent Stock Weakness - Finviz
Market Recap: Will Soleno Therapeutics Inc. stock recover faster than peers2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN
Will Soleno Therapeutics Inc. stock see insider buying2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn
Atika Capital Management LLC Purchases 19,250 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics (NASDAQ:SLNO) Shares Up 8.9%What's Next? - MarketBeat
Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Soleno Therapeutics Inc Azioni (SLNO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):